| ²é¿´: 547 | »Ø¸´: 1 | ||
ÃÀÀöµÄС¹ÃÄïгæ (³õÈëÎÄ̳)
|
[ÇóÖú]
΢Æ×ÇóÖú£¬Ð»Ð»£¡ ÒÑÓÐ1È˲ÎÓë
|
|
TS-9 ÈܼÁ£ºÂȷ ̼Æ×Êý¾ÝÈçÏ£º14.49,21.52,26.15,28.12,38.63,39.17,39.53,52.06,55.06,126.26,134.84. |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁÏÓ뻯¹¤µ÷¼Á
ÒѾÓÐ4È˻ظ´
±¾9Ò»Ö¾Ô¸2 0854µÍ·Öר˶286Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
298Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
²ÄÁÏרҵ344Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
282£¬µçÆø¹¤³Ìרҵ£¬Çóµ÷¼Á£¬²»Ìôרҵ
ÒѾÓÐ6È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á
ÒѾÓÐ28È˻ظ´
²ÄÁÏ085601µ÷¼Á
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸0703»¯Ñ§ÕÐ61×îÖÕÅÅÃû62»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ23È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
½âÆ×ÇóÖú£¨Ö»ÓÐ̼Æ×£©£¬Ð»Ð»ÁË¡£
ÒѾÓÐ3È˻ظ´
΢Æ×ÇóÖú лл
ÒѾÓÐ4È˻ظ´
΢Æ×ÇóÖú£¬¿É·ñÓÐÈËÖ¸µã»òÔõÑù²éµ½´øÓÐÒÑÖªµ¥ÌåµÄºË´ÅÆ×Êý¾ÝÎÄÏ×
ÒѾÓÐ4È˻ظ´
΢Æ×ÇóÖú лл
ÒѾÓÐ3È˻ظ´
ÇóÖú»¯ºÏÎï΢Æ×ËÑË÷
ÒѾÓÐ8È˻ظ´
¼±Çó ÔÚÏßµÈ Î¢Æ×ÇóÖú
ÒѾÓÐ5È˻ظ´
ÇóÖú΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ5È˻ظ´
΢Æ×ÇóÖú»¯ºÏÎï½á¹¹
ÒѾÓÐ4È˻ظ´
΢Æ×Êý¾Ý²éѯÇóÖú
ÒѾÓÐ3È˻ظ´
ÇóÖú΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ8È˻ظ´
ÇóÖúͨ¹ý΢Æ×²éѯ»¯ºÏÎï½á¹¹
ÒѾÓÐ4È˻ظ´
¼±¼±¼±¡£¡£¡£¡£ÇóÖú΢Æ×Êý¾Ý£¨50%ÏàËÆ¶È¾ÍOKÁË£©£¬²»Ê¤¸Ðл£¡
ÒѾÓÐ8È˻ظ´
ÇóÖú£º¸÷λ³æÒ¯£¬Çó΢Æ×£¡°Ë°ÙÀï¼Ó¼±£¡£¡£¡¿¿ÄãÃÇÁË£¡
ÒѾÓÐ19È˻ظ´
cjpballack
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 328 (´óѧÉú)
- ½ð±Ò: 6551.4
- ºì»¨: 8
- Ìû×Ó: 663
- ÔÚÏß: 88.5Сʱ
- ³æºÅ: 2433043
- ×¢²á: 2013-04-23
- ÐÔ±ð: GG
- רҵ: ÖÐҩѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÃÀÀöµÄС¹ÃÄï: ½ð±Ò+15 2015-05-02 10:38:28
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÃÀÀöµÄС¹ÃÄï: ½ð±Ò+15 2015-05-02 10:38:28
|
²éѯ½á¹û£º¹²²éµ½6¸ö»¯ºÏÎï(²éѯ½á¹û½ö¹©²Î¿¼) -------------------------------------------------------------------------------- 1 . 1-Bromotricyclo[4.3.1.1(2,5)]undecane C11H17Br ÏàËÆ¶È:63.6% Journal of Medicinal Chemistry 1979 22 1206-1214 Biologically active polycycloalkanes. 6. Antiviral 1-tricyclo[4.3.1.12,5]undecyl derivatives Yoshiaki Inamoto, Koji Aigami, Naotake Takaishi, Yoshiaki Fujikura, Motoyoshi Ohsugi, Hiroshi Ikeda, Kiyoshi Tsuchihashi, Akira Takatsuki, Gakuzo Tamura Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 2 . (+)-methyl dihydrojasmonate C13H22O3 ÏàËÆ¶È:61.5% Organic letters 2000 2 2959-2962 Enantioselective Synthesis of Both Enantiomers of Methyl Dihydrojasmonate Using Solid−Liquid Asymmetric Phase-Transfer Catalysis Thierry Perrard, Jean-Christophe Plaquevent, Jean-Roger Desmurs, and Dominique H¨¦brault Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 3 . (-)-jasmonic acid ÏàËÆ¶È:61.5% Phytochemistry 2010 71 2019-2023 Biosynthesis of jasmonic acid in a plant pathogenic fungus, Lasiodiplodia theobromae Kohei Tsukada, Kosaku Takahashi, Kensuke Nabeta Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 4 . (− -methyl jasmonate C13H20O3 ÏàËÆ¶È:61.5% Natural Product Communications 2013 8 919-923 Cyclopentanoids from Cyclopentadiene: Synthesis of (− -Methyl jasmonate and (+)-12-Oxophytodienoic acidJunzo Nokami, Kazuhiko Fujii, Yusuke Mizutani, Rikiya Omatsu, Kiyoshi Watanabe, Hiroshi Yasuda and Tsutomu Inokuchi Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 5 . Methyl jasmonate ÏàËÆ¶È:61.5% Molecules 2012 17 14310-14322 Antimicrobial and Cytotoxic Isohexenylnaphthazarins from Arnebia euchroma (Royle) Jonst. (Boraginaceae) Callus and Cell Suspension Culture Harilaos Damianakos, Nadine Kretschmer, Katarzyna Sykłowska-Baranek, Agnieszka Pietrosiuk, Rudolf Bauer and Ioanna Chinou Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 6 . Methyl 9,10-Methanojasmonate C14H22O3 ÏàËÆ¶È:61.5% Flavour and Fragrance Journal 2002 17 267-271 Syntheses and odour descriptions of cyclopropanated compounds 2.1 Analogues of methyl jasmonate Hiromasa Kiyota, Takanori Koike, Emi Higashi and Takayuki Oritani Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ |

2Â¥2015-04-27 14:01:59













»Ø¸´´ËÂ¥
-methyl jasmonate